ABSTRACT
OBJECTIVE:To investigate chemotherapeutic efficacy and safety of Paclitaxel combined with lobaplatin by inter-ventional embolization for cervical cancer. METHODS:Totally 68 cases of cervical cancer patients selected from our hospital dur-ing May 2010-Mar. 2014 were divided into control group and observation group according to therapy plan,with 34 cases in each group. Control group was given Paclitaxel liposome for injection 175 mg/m2 added into 5% Glucose injection 250 mL,ivgtt+Loba-platin for injection 80 mg/m2 added into 5% Glucose injection 250 mL,ivgtt. Observation group was given Paclitaxel liposome for injection 175 mg/m2+Lobaplatin for injection 80 mg/m2+5% Glucose injection 10 mL via percutaneous catheter after selecting uter-ine artery and tumor vessel by arterial catheterization arteriography,gelfoam embolization. Both groups were treated in the first day of every treatment course,21 d as a treatment course,for 3 courses. Clinical efficacies were observed in 2 groups as well as the levels of T lymphocyte subsets(CD4+,CD8+,CD4+/CD8+)before and after treatment. The occurrence of ADR during treatment,lo-cal recurrence and metastasis after 2 years,and survival situation were recorded. RESULTS:The total response rate of observatio group(85.29%)was significantly higher than that of control group(61.76%),with statistical significance(P0.05). After treat-ment,CD4+and CD4+/CD8+of 2 groups were increased significantly,while CD8+was decreased significantly;above indexes of ob-servation group were improved significantly compared to control group,with statistical significance (P0.05). CONCLUSIONS:Paclitaxel combined with lobaplatin by interventional embolization show definite chemotherapeutic efficacy for cervical cancer,and can improve the levels of T lymphocyte subset with good safety.
ABSTRACT
Objective: To analyze the therapeutic effect of pulmonary surfactant [PS] in combination with nasal continuous positive airway pressure [NCPAP] therapy on neonatal respiratory distress syndrome [NRDS]
Methodology: Forty-nine neonates who were diagnosed as NRDS and admitted in our hospital from May 2014 to June 2015 were selected and divided into an observation group and a control group. The observation group was treated with PS and NCPAP. The control group was treated only with NCPAP. The clinical symptoms, pulmonary X-ray, arterial partial pressure of oxygen [PaO[2]] and prognosis of the two groups were observed
Results: Twelve hours after treatment, the partial pressure of carbon dioxide and oxygenation index decreased significantly [P<0.05], and PaO[2] and ratio of arterial/pulmonary oxygen partial pressures increased significantly [P<0.05]. Pulmonary X-ray examination showed that 78.3% of the observation group and 53.8% of the control group were relieved 12-24 hour after treatment, between which the difference was statistically significant [P<0.05]. The improvement rate of the observation group was significantly higher than that of the control group [82.6% vs. 57.7%, P<0.05], the incidence of complications was significantly lower in the observation group [P<0.05], and the average length of stay in the observation group was significantly shorter [P<0.05]
Conclusion: Both methods effectively treated NRDS, but PS in combination with NCPAP better improved oxygenation, reduced mortality and incidence of complications
ABSTRACT
Objective: To study the clinical effect of ganglioside [GM] and fructose-1, 6-diphosphate [FDP] on neonatal heart and brain injuries after asphyxia
Methods: Ninety-one neonates with asphyxia neonatal heart and brain injuries were randomly divided into an observation group and a control group. Both groups were given symptomatic treatment as soon as possible. On this basis, the observation group was given 200 ml of 5% glucose injection and 20 mg of GM and 250 mg/kg-d FDP by intravenous infusion. The above two drugs were given once a day for 14 days. The control group was given 20 ml of 5% glucose injection, 2 ml of cerebrolysin and 250 mg/kg-d FDP by intravenous infusion, once a day for 14 days. Both groups were administered on the first day after admission, and the course of treatment was 14 days. The treatment outcomes of the two groups were compared by detecting the levels of glycogen phosphorylase isoenzyme BB [GPBB], cTn-l and CK-MB, MRI results and Neonatal Behavioral Neurological Assessment [NBNA] scores before and after treatment
Results: The levels of GPBB, cTn-l and CK-MB in the observation group were significantly higher than those of normal neonates. After treatment, the levels of cTn-l and CK-MB in the observation group were closer to those of normal neonates compared with the control group, with significant differences [P<0.05]. There was a significant difference in the brain MRI examination between the two groups [P<0.05]. The NBNA scores of the two groups were significantly different before and after treatment [P<0.05]. The total effective rate of the observation group was significantly higher than that of the control group [P<0.05]. Conclusion: Neonatal heart and brain injuries after asphyxia can be well treated by combining GM with FDP
Subject(s)
Humans , Male , Female , Infant, Newborn , Fructosediphosphates , Heart Injuries , Brain Injuries , Asphyxia , Gangliosides , Infant, Newborn, Diseases , Creatine Kinase, MB Form/bloodABSTRACT
Breast cancer is the principal cause of death in malig-nancy women , usually treated with the combination of surgery , chemotherapy , radiotherapy and endocrinotherapy .With the de-velopment of cell biology , molecular biology , immunology, im-munotherapy becomes a new field of breast cancer treatment .In this review, we discuss new findings in breast cancer immuno-therapy , including recent successes with bispecific antibodies and immune checkpoint blockade .We also discuss therapeutic cancer vaccines and highlight several additional immunotherapy modalities in early stages of development .